Company Intelligence

OpenEvidence

Clinical AI answers grounded in medical literature citations

In this profile

Quick Facts

Executive Summary

OpenEvidence offers an AI system that answers clinical questions with references to medical literature. The official website positions the product for clinicians who need sourced answers rather than free-form generative text.This profile uses OpenEvidence’s public website as the authoritative source.

Why It Matters

OpenEvidence represents citation-first clinical LLM search as an alternative to uncited chatbots in medicine.

Products

Connected Reports

Connected Insights

Industries

Technologies

Introduction

OpenEvidence offers an AI system that answers clinical questions with references to medical literature. The official website positions the product for clinicians who need sourced answers rather than free-form generative text.

This profile uses OpenEvidence’s public website as the authoritative source.

What the company does

AI clinical information product that answers medical questions with citations to peer-reviewed literature, according to the official site.

Who it serves

Clinicians seeking literature-grounded answers at the point of care or research.

Company background

United States

Product and AI capabilities

AI clinical information product that answers medical questions with citations to peer-reviewed literature, according to the official site.

Key developments

Why it matters

OpenEvidence represents citation-first clinical LLM search as an alternative to uncited chatbots in medicine.

Sector context

See Brel’s Healthcare sector hub for related profiles.

Sources and references

Official: https://www.openevidence.com

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe